Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Greco EV, Russo G, Giandalia A, Viazzi F, Pontremoli R, De Cosmo S
or degree of disability or dependence with daily tasks (4 trials) (102)
Nature Communications , 9 , 2802
Membership includes ongoing communication with licensed providers, nurse-led coaching, and an insurance concierge for cost support
US$ 27.29
US$ 22.42
US$ 23.81
US$ 26.66
US$ 26.78
